FDG-PET/CT based response-adapted treatment

It has been shown that [(18)F]fluorodeoxyglucose (FDG)-positron emission tomography (PET) provides robust and reproducible data for early metabolic response assessment in various malignancies. This led to the initiation of several prospective multicenter trials in malignant lymphoma and adenocarcino...

Descripción completa

Detalles Bibliográficos
Autores principales: de Geus-Oei, Lioe-Fee, Vriens, Dennis, Arens, Anne I.J., Hutchings, Martin, Oyen, Wim J.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2012
Materias:
Focus on 1: Emergency Paradigms in Pet
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460598/
https://www.ncbi.nlm.nih.gov/pubmed/23023063
http://dx.doi.org/10.1102/1470-7330.2012.9006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460598/
https://www.ncbi.nlm.nih.gov/pubmed/23023063
http://dx.doi.org/10.1102/1470-7330.2012.9006

Ejemplares similares